Back to Search Start Over

Uptake of PrEP and condom and sexual risk behavior among MSM during the ANRS IPERGAY trial

Authors :
Luis Sagaon-Teyssier
Marie Suzan-Monti
Baptiste Demoulin
Catherine Capitant
Nicolas Lorente
Marie Préau
Marion Mora
Daniela Rojas Castro
Christian Chidiac
Julie Chas
Laurence Meyer
Jean-Michel Molina
Bruno Spire
null for the ANRS IPERGAY Study Group
ORS PACA
Sciences Economiques et Sociales de la Santé & Traitement de l'Information Médicale (SESSTIM - U1252 INSERM - Aix Marseille Univ - UMR 259 IRD)
Institut de Recherche pour le Développement (IRD)-Aix Marseille Université (AMU)-Institut National de la Santé et de la Recherche Médicale (INSERM)
Institut de Recherche pour le Développement (IRD)
Sciences Economiques et Sociales de la Santé & Traitement de l'Information Médicale (SESSTIM - U912 INSERM - Aix Marseille Univ - IRD)
Institut de Recherche pour le Développement (IRD)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Aix Marseille Université (AMU)
Institut National de la Santé et de la Recherche Médicale (INSERM)
Groupe de Recherche en Psychologie Sociale (GRePS)
Université Lumière - Lyon 2 (UL2)
Grupo de Investigación en Energía y Medioambiente [Bucaramanga]] (GIEMA)
Universidad Industrial de Santander [Bucaramanga] (UIS)
Service des maladies infectieuses et tropicales [CHU Tenon]
CHU Tenon [AP-HP]
Sorbonne Université (SU)-Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Sorbonne Université (SU)-Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)
INSERM U1018
Faculté de Médecine Paris-Sud, Le Kremlin Bicêtre
Service de maladies infectieuses et tropicales [Saint-Louis]
Université Paris Diderot - Paris 7 (UPD7)-Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Groupe Hospitalier Saint Louis - Lariboisière - Fernand Widal [Paris]
Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)
Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Sorbonne Université (SU)
Centre de recherche en épidémiologie et santé des populations (CESP)
Université de Versailles Saint-Quentin-en-Yvelines (UVSQ)-Université Paris-Sud - Paris 11 (UP11)-Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Hôpital Paul Brousse-Institut National de la Santé et de la Recherche Médicale (INSERM)
Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Université Paris Diderot - Paris 7 (UPD7)-Groupe Hospitalier Saint Louis - Lariboisière - Fernand Widal [Paris]
Greps, Laboratoire
Service de Maladies infectieuses et tropicales [CHU Tenon]
Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Sorbonne Université (SU)-Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Sorbonne Université (SU)
Source :
AIDS Care, AIDS Care, Taylor & Francis (Routledge), 2016, ⟨10.1080/09540121.2016.1146653⟩, AIDS Care, 2016, ⟨10.1080/09540121.2016.1146653⟩
Publication Year :
2016
Publisher :
HAL CCSD, 2016.

Abstract

International audience; The double-blind phase of the randomized ANRS IPERGAY trial, evaluating sexual activity-based oral HIV pre-exposure prophylaxis (PrEP), was conducted among high-risk men who have sex with men (MSM). Results showed an 86% (95% CI: 40–98) relative reduction in HIV incidence amongparticipants with tenofovir disoproxil fumarate–emtricitabine vs. placebo. The present pooled analysis aimed to analyze (i) participants’ adherence to the prescribed treatment and/or condom use during sexual intercourse and (ii) sexual behavior during the double-blind phase of the study. Four hundred MSM were enrolled in the trial. Every 2 months they completed online questionnaires collecting sexual behavior and PrEP adherence data regarding their most recent sexual intercourse. A total of 2232 questionnaires (M0–M24) were analyzed. Changes over time were evaluated using a mixed model accounting for multiple measures. Irrespective of sexual partner and practice type, on average, 42.6% (min: 32.1–max: 45.8%) reported PrEP use only during their most recent episode of sexual intercourse; 29% (22.9–35.6%) reported both PrEP and condom use; 11.7% (7.2–18.9%) reported condom-use only, and 16.7% (10.8–29.6%) reported no PrEP or condom use with no significant change during the study. Scheduled (i.e.,correct) PrEP use was reported on average by 59.0% (47.2–68.5%) of those reporting PrEP use during their most recent sexual intercourse. Overall, 70.3% (65.3–79.4%) and 69.3% (58.3–75.4%) of participants reported, respectively, condomless anal and condomless receptive anal intercourse during their most recent sexual encounter without significant change during followup. Overall, on average 83.3% (min: 70.4–max: 89.2%) of participants protected themselves by PrEP intake or condom use or both during the trial, and no increase in at-risk sexual practices was observed. None of these indicators showed significant trend during the follow-up, although we found a tendency toward decrease (p = .19) of the median number of sexual partners strengthening the absence of behavioral disinhibition. On-demand PrEP within a comprehensive HIV prevention package could improve prevention in MSM.

Details

Language :
English
ISSN :
09540121 and 13600451
Database :
OpenAIRE
Journal :
AIDS Care, AIDS Care, Taylor & Francis (Routledge), 2016, ⟨10.1080/09540121.2016.1146653⟩, AIDS Care, 2016, ⟨10.1080/09540121.2016.1146653⟩
Accession number :
edsair.doi.dedup.....07081856f09fa79f327daace93adb05a
Full Text :
https://doi.org/10.1080/09540121.2016.1146653⟩